Filing Flows › Iradimed (IRMD) › Gross margin
Iradimed (IRMD) gross margin by quarter
Iradimed's gross margin was 76.3% in Q3 2026 (third quarter 2026), +2.2 pts from Q2 2026. Over the last 7 quarters it ranged from 74.1% (Q2 2026) to 78.2% (Q2 2025).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 76.3% | +2.2 pts | -1.5 pts |
| Q2 2026 | 74.1% | -2.4 pts | -4.1 pts |
| Q1 2026 | 76.5% | +1.4 pts | +0.4 pts |
| Q4 2025 | 75.1% | -2.7 pts | — |
| Q3 2025 | 77.8% | -0.4 pts | — |
| Q2 2025 | 78.2% | +2.1 pts | — |
| Q1 2025 | 76.1% | — | — |
Q3 2026 at a glance
Iradimed, Q3 2026: revenue $24.2M (+14% year over year), operating margin 33.6%, net earnings $6.5M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Iradimed's gross margin?
Iradimed's gross margin was 76.3% in Q3 2026 (third quarter 2026), +2.2 pts from Q2 2026.
How has Iradimed's gross margin changed?
Over the last 7 quarters it ranged from 74.1% (Q2 2026) to 78.2% (Q2 2025).